2004
DOI: 10.4049/jimmunol.173.3.2199-c
|View full text |Cite
|
Sign up to set email alerts
|

Distinct Transcriptional Programs Activated by Interleukin-10 with or without Lipopolysaccharide in Dendritic Cells: Induction of the B Cell-Activating Chemokine, CXC Chemokine Ligand 13.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
37
0

Year Published

2004
2004
2012
2012

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 29 publications
(40 citation statements)
references
References 0 publications
3
37
0
Order By: Relevance
“…In agreement with the human data (Perrier et al 18 and references therein; Huang et al 19 ), treatment with LPS had a profound effect on the transcriptional profile of the mouse DC. Additionally, the set of mouse genes modulated by LPS corresponds to those reported for human.…”
Section: Transcriptional Profile Of Lps-treated DCsupporting
confidence: 88%
“…In agreement with the human data (Perrier et al 18 and references therein; Huang et al 19 ), treatment with LPS had a profound effect on the transcriptional profile of the mouse DC. Additionally, the set of mouse genes modulated by LPS corresponds to those reported for human.…”
Section: Transcriptional Profile Of Lps-treated DCsupporting
confidence: 88%
“…This phenomenon, which we previously reported in a published abstract [27], was recently confirmed independently by Carlsen et al [19]. They also extended this observation by demonstrating, in agreement with the work of Perrier et al [28], that CXCL13 can be produced by non-stromal hemopoietic cells of the monocyte lineage. Having established that CXCL13 can be produced in the absence of an advanced organizational stage and a critical cell mass (Grade 3), we next examined the relationship between CXCL13 production and lymphoid tissue formation as it progresses through enlargement phases analyzed according to the grading score.…”
Section: Cxcl13 In Situ Production and Microstructural Lymphoid Organsupporting
confidence: 87%
“…Thus, regardless of the actual identity of this band, it seems unlikely that the mechanisms underlying the action of IL-10 in neutrophils involve a modulation of Bcl-3. Another potential intermediate for the modulation of gene expression by IL-10 is SOCS-3, an intracellular protein that is rapidly induced by IL-10 in many cell types [26][27][28] and whose overexpression has been shown to inhibit numerous pro-inflammatory actions of LPS in murine macrophage J774 cells [26] as well as the phosphorylation of STAT3 tyrosine residues activated by IL-10 [26,29]. Fig.…”
Section: Resultsmentioning
confidence: 99%
“…In other words, the up-regulation of IL-10R1 (and the subsequent formation of a fully competent IL-10R) does not suffice per se to allow IL-10 to readily modulate the expression of LPS-induced cytokine mRNA, as observed in "time 0" PBMC. We have then investigated the role of potential newly synthesized candidates recently proposed to take part in the antiinflammatory activities of IL-10 or in the mechanisms of suppression of TNF-a production, including SOCS-3, HO-1, and Bcl-3 [22,[25][26][27][28]. According to our experiments, the induction of antigenic SOCS-3, HO-1, and Bcl-3 in neutrophils appeared, again, not sufficient for IL-10 to exert a modulatory action on gene expression at early times after LPS stimulation.…”
Section: Requirement Of De Novo Protein Synthesis For the Inhibitory mentioning
confidence: 99%